Back to Search
Start Over
Designing a trial for neonatal seizure treatment.
- Source :
-
Seminars in fetal & neonatal medicine [Semin Fetal Neonatal Med] 2018 Jun; Vol. 23 (3), pp. 213-217. Date of Electronic Publication: 2018 Feb 12. - Publication Year :
- 2018
-
Abstract
- Neonatal seizures are widely considered a neurological emergency with a need for prompt treatment, yet they are known to present a highly elusive target for bedside clinicians. Recent studies have suggested that the design of a neonatal seizure treatment trial will profoundly influence the sample size, which may readily increase to hundreds or even thousands as the achieved effect size diminishes to clinical irrelevance. The self-limiting and rapidly resolving nature of neonatal seizures diminishes the measurable treatment effect every hour after seizure onset and any effect may potentially be confused with spontaneous resolution, precluding the value of many observational studies. The large individual variability in seizure occurrence over time and between etiologies challenges group comparisons, while the absence of clinical signs mandates quantification of seizure occurrence with continuous multi-channel EEG monitoring. A biologically sound approach that views neonatal seizures as a functional cot-side biomarker rather than an object to treat can overcome these challenges.<br /> (Copyright © 2018 Elsevier Ltd. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1878-0946
- Volume :
- 23
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Seminars in fetal & neonatal medicine
- Publication Type :
- Academic Journal
- Accession number :
- 29467103
- Full Text :
- https://doi.org/10.1016/j.siny.2018.02.005